GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) » Definitions » Debt-to-Asset

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Debt-to-Asset : 0.22 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is JSP Pharmaceutical Manufacturing (Thailand) PCL Debt-to-Asset?

JSP Pharmaceutical Manufacturing (Thailand) PCL's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ฿100.44 Mil. JSP Pharmaceutical Manufacturing (Thailand) PCL's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ฿204.70 Mil. JSP Pharmaceutical Manufacturing (Thailand) PCL's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was ฿1,371.71 Mil. JSP Pharmaceutical Manufacturing (Thailand) PCL's debt to asset for the quarter that ended in Mar. 2024 was 0.22.


JSP Pharmaceutical Manufacturing (Thailand) PCL Debt-to-Asset Historical Data

The historical data trend for JSP Pharmaceutical Manufacturing (Thailand) PCL's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JSP Pharmaceutical Manufacturing (Thailand) PCL Debt-to-Asset Chart

JSP Pharmaceutical Manufacturing (Thailand) PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
0.45 0.43 0.15 0.14 0.22

JSP Pharmaceutical Manufacturing (Thailand) PCL Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.15 0.21 0.22 0.22

Competitive Comparison of JSP Pharmaceutical Manufacturing (Thailand) PCL's Debt-to-Asset

For the Packaged Foods subindustry, JSP Pharmaceutical Manufacturing (Thailand) PCL's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JSP Pharmaceutical Manufacturing (Thailand) PCL's Debt-to-Asset Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, JSP Pharmaceutical Manufacturing (Thailand) PCL's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where JSP Pharmaceutical Manufacturing (Thailand) PCL's Debt-to-Asset falls into.



JSP Pharmaceutical Manufacturing (Thailand) PCL Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

JSP Pharmaceutical Manufacturing (Thailand) PCL's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(108.595 + 181.935) / 1335.675
=0.22

JSP Pharmaceutical Manufacturing (Thailand) PCL's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(100.442 + 204.695) / 1371.711
=0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


JSP Pharmaceutical Manufacturing (Thailand) PCL  (BKK:JSP-F) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


JSP Pharmaceutical Manufacturing (Thailand) PCL Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of JSP Pharmaceutical Manufacturing (Thailand) PCL's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Business Description

Traded in Other Exchanges
N/A
Address
No. 255 and 257, Soi Sathupradit, 58, Bang Pongphang, Yannawa, Bangkok, THA, 10120
JSP Pharmaceutical Manufacturing (Thailand) PCL is engaged in producing drugs, dietary supplements, cosmetics, herbs, and dietary supplements in the form of vitamins including healthy coffee Ready. Its segments include Manufacturing and distribution of products under the customer's Brand name and Own Brand name. The majority of the revenue comes from the manufacturing and distribution of products under the customer's brand name. The Group is managed and operates principally in Thailand.

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Headlines

No Headlines